-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
International Stem Cell CORP quarterly/annual Cost of Revenue history and growth rate from 2010 to 2023.
- International Stem Cell CORP Cost of Revenue for the quarter ending September 30, 2024 was $974K, a 24.7% increase year-over-year.
- International Stem Cell CORP Cost of Revenue for the twelve months ending September 30, 2024 was $3.64M, a 5.3% increase year-over-year.
- International Stem Cell CORP annual Cost of Revenue for 2023 was $3.18M, a 2.69% decline from 2022.
- International Stem Cell CORP annual Cost of Revenue for 2022 was $3.27M, a 11.4% increase from 2021.
- International Stem Cell CORP annual Cost of Revenue for 2021 was $2.94M, a 5.54% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)